Kawabata M, Ogawa T, Takabatake T
Fourth Department of Internal Medicine, Shimane Medical University, Izumo, Japan.
Kidney Int Suppl. 1998 Sep;67:S228-30. doi: 10.1046/j.1523-1755.1998.06757.x.
The role of adenosine A1 receptors in the glomerular microcirculation and tubuloglomerular feedback (TGF) was studied in anesthetized Sprague-Dawley rats. TGF activity was assessed as the reduction in proximal tubular stop-flow pressure (SFP) on establishing orthograde perfusion of the loop of Henle with artificial tubular fluid at 40 nl/min. Administration of a selective A1 receptor antagonist, KW-3902 (0.5 microg/kg/min i.v.), increased fractional excretion of Na (FE(Na)) 4.3-fold without changing blood pressure, glomerular filtration rate, renal plasma flow, or filtration fraction. SFP in the absence of distal flow (SFP0) increased, and TGF-mediated SFP reduction was suppressed dose dependently [by 23 +/- 2% from an SFP0 of 34 +/- 1 mm Hg, by 15 +/- 4% from 36 +/- 2 mm Hg, and by 2 +/- 1% from 39 +/- 1 mm Hg during vehicle, low- and high-dose infusions (0.5 and 5.0 microg/kg/min), respectively]. Intratubular or peritubular capillary administration of 10(-4) M KW-3902 completely suppressed TGF without affecting SFP0. TGF suppression and elevation of SFP0 during systemic A1 blockade indicated vasodilation, both in the afferent arteriole and more proximal preglomerular vessels. Inhibition of tubular Na reabsorption combined with TGF suppression allowed the marked natriuresis. TGF suppression through systemic, luminal, and peritubular application of the drug suggest that juxtaglomerular apparatus A1 receptors are important in the control of glomerular microcirculation.
在麻醉的Sprague-Dawley大鼠中研究了腺苷A1受体在肾小球微循环和管球反馈(TGF)中的作用。TGF活性通过在以40 nl/min的速度用人工肾小管液对亨利袢进行顺行灌注时近端肾小管停流压力(SFP)的降低来评估。给予选择性A1受体拮抗剂KW-3902(0.5 μg/kg/min静脉注射)可使钠的分数排泄(FE(Na))增加4.3倍,而不改变血压、肾小球滤过率、肾血浆流量或滤过分数。无远端血流时的SFP(SFP0)增加,并且TGF介导的SFP降低呈剂量依赖性受到抑制[在给予溶媒、低剂量和高剂量输注(0.5和5.0 μg/kg/min)期间,分别从34±1 mmHg的SFP0降低23±2%,从36±2 mmHg降低15±4%,从39±1 mmHg降低2±1%]。在肾小管内或肾小管周围毛细血管给予10(-4) M KW-3902可完全抑制TGF,而不影响SFP0。全身A1受体阻断期间TGF的抑制和SFP0的升高表明在入球小动脉和更靠近肾小球前的血管中均有血管舒张。肾小管钠重吸收的抑制与TGF的抑制相结合导致明显的利钠作用。通过全身、管腔和肾小管周围应用该药物抑制TGF表明,球旁器A1受体在肾小球微循环的控制中起重要作用。